Genscript Biotech CorpEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 17.2 HKD | 19,4 HKD | 10,36 HKD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - HKD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 2.184.705.170 | - | - |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Genscript Biotech Corp
Mitarbeiter 6.165
Handelsplatz HK
Ticker Symbol 1548
IPO Datum -
Adresse Dah Sing Financial Centre, Wan Chai, Hong Kong
Webseite https://www.genscript.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Jiange Meng | Executive Chairman |
| 2 | Ms. Weihui Shao | CEO & COO |
| 3 | Ms. Ye Wang M.S. | Co-Founder, President & Executive Director |
| 4 | Dr. Fangliang Zhang EMBA, Ph.D. | Co-Founder & Executive Director |
| 5 | Dr. Li Zhu Ph.D. | Chief Strategy Officer & Executive Director |
| 6 | Mr. Jing Zhou | Chief Financial Officer |
| 7 | Dr. Kening Li J.D. | General Counsel & Chief Compliance Officer |
| 8 | Dr. Raymond Miller | Head of Corporate Communications |
| 9 | Ms. Aylin Kosova Bilgin | Chief Marketing Officer for GenScript Life Science Group |
| 10 | Dr. Bhama Parimoo | Head of Global Diversity, Equity & Inclusion(DEI) |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.